Menu

Bad Blood Between California Universities

The University of California, San Diego, is suing the University of Southern California and a former employee over alleged data theft, among other charges of academic animosity.

Jul 8, 2015
Bob Grant

WIKIMEDIA, BRIAN TURNERTwo California universities are locked in a nasty legal dispute. The University of California, San Diego (UCSD), is suing the University of Southern California (USC), charging that a UCSD researcher tried to move his whole lab and a $55 million federal research grant to USC, according to the Los Angeles Times. The suit, filed last week in San Diego Superior Court, alleges that Paul Aisen, an Alzheimer’s disease researcher who moved from UCSD to USC last month, illegally conspired to abscond with data and other assets, essentially transplanting his lab to USC.

That UCSD is crying foul is somewhat surprising. Universities routinely recruit top researchers, luring them to new positions at new institutions. But UCSD says that USC crossed the line by committing contract interference, civil conspiracy, and “computer crimes” in poaching Aisen. According to the suit, Aisen left UCSD with eight colleagues, seeking to rebuild his lab and shift his $55 million dollar National Institute on Aging grant to USC. “We are proud of our work, grateful for our partners and disappointed that one faculty member has chosen to separate in such a way that puts the ADCS’ [Alzheimer's Disease Cooperative Study] work in jeopardy,” UCSD Chancellor Pradeep Khosla wrote in a statement to the LA Times. The paper reported Sunday (July 5) that UCSD is seeking an undisclosed sum of money in the dispute.

USC officials denied any wrongdoing. “We are surprised and disappointed that the University of California San Diego elected to sue its departing faculty member and his team, as well as USC, rather than manage this transition collaboratively, as is the well-accepted custom and practice in academia,” USC said in a statement to the LA Times.

UCSD and USC have a history of chilly relations. When USC made a failed bid to take over the ailing Scripps Research Institute last year, UCSD’s Khosla suggested that his university would make a more suitable partner for Scripps.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.